Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2026 16:01 ET | Source: Senseonics Holdings, Inc.

Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results

Generated Q1 revenue of $11.7 million, an increase of 87% year-over-year Expect full-year revenue in the range of $60M - $64M (previously $58M to $62M) Strong strategic and commercial progress,...
May 07, 2026 02:00 ET | Source: Shell plc

Shell Plc 1st Quarter 2026 Unaudited Results

SHELL PLC1st QUARTER 2026 UNAUDITED RESULTS SUMMARY OF UNAUDITED RESULTSQuarters$ million Q1 2026Q4 2025Q1 2025 Reference5,6944,1344,780Income attributable to...
April 08, 2026 08:00 ET | Source: Amarin Corporation plc

American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction

DUBLIN and BRIDGEWATER, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin”), a company committed to advancing the science of cardiovascular disease (CVD)...
March 18, 2026 08:30 ET | Source: Amarin Corporation plc

Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline

DUBLIN and BRIDGEWATER, N.J., March 18, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin”), a company committed to advancing the science of cardiovascular disease (CVD)...
March 16, 2026 08:15 ET | Source: Amarin Corporation plc

New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

DUBLIN and BRIDGEWATER, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today...
March 02, 2026 16:01 ET | Source: Senseonics Holdings, Inc.

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system...
March 02, 2026 08:00 ET | Source: Amarin Corporation plc

Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology

Peer-reviewed paper indicates icosapent ethyl (IPE) was associated with fewer total hospitalizations and fewer days lost due to hospitalization and death, providing additional insights on the effects...
February 05, 2026 02:00 ET | Source: Shell plc

Shell Plc 4th Quarter 2025 and Full Year Unaudited Results

SHELL PLC 4th QUARTER 2025 AND FULL YEAR UNAUDITED RESULTS SUMMARY OF UNAUDITED RESULTSQuarters$ million Full yearQ4 2025Q3 2025Q4...
January 12, 2026 08:00 ET | Source: Senseonics Holdings, Inc.

Senseonics Announces Preliminary Unaudited Revenue for Fourth Quarter 2025 and Provides Business Update

Preliminary unaudited revenue expected to be approximately $14.2 million for Q4 2025, an increase of 71% year-over-year Introduced 2026 revenue guidance of $58-$62 million Expects to report fourth...
December 04, 2025 04:46 ET | Source: Shell plc

Shell plc Announces Final Results of Exchange Offers

Press Release December 4, 2025 Shell plc Announces Final Results of Exchange Offers Shell plc (“Shell”) (LSE: SHEL) (NYSE: SHEL) (AEX: SHELL) today announces the final results of its previously...